Rand Corp. on Monday reported statistically significant increases in some guideline-concordant care that was exempted from prospective utilization review in the first 30 days of an injury, but the generally modest effects indicate that approval rates for early treatment requests in California were already above 90%. In addition to recommending that the Legislature consider expanding the types of treatments that are exempt from prospective review…  Read more Â»